3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
23
Sarcoma
18
Neoplasms
8
Neoplasm Metastasis
8
Breast Neoplasms
8
Ovarian Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Fallopian Tube Neoplasms
6
Liposarcoma
5
Leiomyosarcoma
5
Hemangiosarcoma
5
Sarcoma, Synovial
4
Neurofibrosarcoma
4
Lung Neoplasms
4
Kidney Neoplasms
4
Histiocytoma, Malignant Fibrous
4
Urinary Bladder Neoplasms
3
Recurrence
3
Prostatic Neoplasms
3
Glioblastoma
3
Thyroid Carcinoma, Anaplastic
2
Small Cell Lung Carcinoma
2
Sarcoma, Alveolar Soft Part
2
Pancreatic Neoplasms
2
Neuroendocrine Tumors
2
Melanoma
2
Gliosarcoma
2
Fibrosarcoma
2
Dermatofibrosarcoma
2
Clear-cell metastatic renal cell carcinoma
2
Interventions
Gemcitabine
31
Cisplatin
21
pembrolizumab
8
Fluorouracil
6
Oxaliplatin
5
Capecitabine
5
130-nm albumin-bound paclitaxel
5
durvalumab
4
Taxes
4
Albumin-Bound Paclitaxel
4
pemigatinib
3
infigratinib
3
atezolizumab
3
Specimen Handling
3
Radiosurgery
3
Platinum
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Carboplatin
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
tremelimumab
2
trametinib
2
olaparib
2
ivosidenib
2
derazantinib
2
cobimetinib
2
Trastuzumab
2
Radiotherapy
2
Panitumumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Cholangiocarcinoma
×
pazopanib
×
Clear all
No trials found.